Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population

American Journal of Hypertension

Volumn 27, Issue 8, 2014, Pages 1079-1086

  Cuspidi, Cesare ^a,b   Facchetti, Rita ^a   Bombelli, Michele ^a   Sala, Carla ^c   Grassi, Guido ^a,d   Mancia, Giuseppe ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

Blood pressure; Cardiovascular prognosis; Echocardiography; Hypertension; Left ventricular mass; Wall thickness

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BODY SURFACE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE MASS INDEX; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; MIDDLE AGED; PATHOLOGY; POPULATION; PROGNOSIS; REPRODUCIBILITY;

ADULT; AGED; BLOOD PRESSURE; BODY SURFACE AREA; CARDIOVASCULAR DISEASES; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ITALY; MALE; MIDDLE AGED; MYOCARDIUM; POPULATION; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84905865317     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu019     Document Type: Article

References (36)

1. Kannel WB, Gordon T, Offut D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med 1969; 71: 89-105.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study. N Engl J Med 1990; 322: 1561-1566.
3. Bombelli M, Facchetti R, Carugo S, Madotto M, Arenare F, Quarti-Trevano F, Capra A, Giannattasio C, Dell'Oro R, Sega R, Mancia G. Left ventricular hypertrophy increases cardiovascular risk independently of in-and out-of office blood pressure values. J Hypertens 2009; 27: 2458-2464.
4. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
5. Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, Ambrosio G. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001; 104: 2039-2044.
6. Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Leonetti G,Sarti C,Tuomilehto J, Webster J,Yodfat Y. Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension 2004; 44: 459-464.
7. Gosse P, Jan E, Coulon P, Cremer A, Papaioannou G, Yeim S. ECG detection of left ventricular hypertrophy: the simpler, the better? J Hypertens 2012; 30: 990-996.
8. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Am Intern Med 1992; 117: 831-836.
9. Larsen GC, Griffith JL, Beshansky JR, D'Agostino RB, Selker HP. Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia-its influence on diagnosis, triage and short-term prognosis: a multicenter study. J Gen Intern Med 1994; 9: 666-673.
10. Hawkins NM, Wang D, McMurray JJV, Pfeffer AM, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn FG. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart 2007; 93: 59-64.
11. Silbeberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-290.
12. Levy D, Garrison RJ, Savage D, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1988; 110: 101-107.
13. Levy D, Salomon M, D'Agostino RB, Belanger AJ. Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90: 1786-1793.
14. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001; 104: 1615-1621.
15. Verdecchia P, Angeli F, Borgioni C, Gattobigio R, de Simone G, Devereux RB, Porcellati C. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens 2003; 16: 895-899.
16. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141: 334-341.
17. Devereux RB, Casale PN, Kligfield P, Eisemberg RR, Miller D, Campo R, Alonso DR. Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation, and dilated cardiomyopathy. Am J Coll Cardiol 1986; 57: 1388-1393.
18. Cuspidi C, Valerio C, Sala C, Muiesan ML, Grandi AM, Palumbo G, Pini C, Leonetti G, Zanchetti A, Mancia G. The Hyper-Pract study: a multicenter survey of the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice. Blood Press 2008; 17: 124-128.
19. Cuspidi C, Negri F, Giudici V, Capra A, Muiesan ML, Agabiti-Rosei E, de Simone G, De Luca N, Tocci G, Morganti A. Echocardiography in clinical practice: the burden of hypertension. A multicenter Italian study. J Hum Hypertens 2010; 24: 395-402.
20. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bombelli M, Giannattasio C, Zanchetti A, Mancia G. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressioni Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104: 1385-1392.
21. Cuspidi C, Facchetti R, Sala C, Bombelli M, Negri F, Carugo S, Sega R, Grassi G, Mancia G. Normal values of left ventricular mass: findings from the PAMELA study. J Hypertens 2012; 30: 997-1003.
22. Devereux RB, Reickek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
23. Anderson RN, Rosemberg HM. Disease classification: measuring the effect of the Tenth Revision of the International Classification of Diseases on cause-of-death in the United States. Stat Med. 2003; 15: 1551-1570.
24. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana GC, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13: 1377-1390.
25. Wiley Cox DR. Regression models and life tables (with discussion). J Royal Stat. Soc Series B 1972; 34: 187-220.
26. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
27. Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Hand J, King A, Barre PE. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 1990; 55: 114-120.
28. Barbieri A, Bursi F, Mantovani F, Valenti C, Quaglia M, Berti E, Marino M, Modena MG. Left ventricular hypertrophy reclassification and death: application of the recommendation of the American Society of Echocardiography/European Association of Echocardiography. Eur Heart J Cardiovasc Imaging 2012; 13: 109-117.
29. Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes J III, Feinleib M, Castelli WP. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 1987; 75: 126-133.
30. Leibowitz D, Planer D, Ben-Ibgi F, Rott D, Weiss AT, Bursztyn M. Measurement of wall thickness alone does not accurately assess the presence of left ventricular hypertrophy. Clin Exp Hypertens 2007; 29: 119-125.
31. Gidding SS. Controversies in the assessment of left ventricular mass. Hypertension 2010;56: 26-28.
32. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer J, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen S, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Simes PE, Sleight P, Viigimaa M, Waeber W, Zannad F. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357.
33. Eguchi K, Ishikawa J, Hoshide S, Ishikawa S, Pickering TG, Schwartz JE, Homma S, Shimada K, Kario K. Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis diabetic and in non-diabetic hypertensive subjects. Am Heart J 2007; 154: 79e9-15.
34. Dewey FE, Rosenthal D, Murphy DJ, Froelicher VF, Ashley EA. Does size matter? Clinical applications of scaling cardiac size and function for body size. Circulation 2008; 117;2279-2287.
35. de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, for the Strong Heart Study Investigators. Normalization for body size and population attributable risk of left ventricular hypertrophy. Am J Hypertens 2005; 18: 191-196.
36. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-586.